Tuesday, 02 January 2024 12:17 GMT

Tiktok 'Paracetamol Challenge' Concerns Swiss Doctors


(MENAFN- Swissinfo) Several cantons in western Switzerland are warning against the dangerous "Paracetamol Challenge" currently rampant on social media such as TikTok.

This content was published on January 31, 2025 - 09:46 2 minutes Keystone-SDA
  • Deutsch de “Paracetamol-Challenge” auf Tiktok beunruhigt Ärzte Original Read more:“Paracetamol-Challenge” auf Tiktok beunruhigt Ärzt

+ Get the most important news from Switzerland in your inbox

This involves young people challenging each other to take high doses of the painkiller paracetamol – often with fatal consequences

The health authorities of the cantons of Fribourg, Jura and Vaud warned the population of the risks of this practice on Thursday. Pharmacies are called upon to be more vigilant when selling this medication to young people, the cantons announced.

+ Read what's new for Swiss AI in 2025

Paracetamol is one of the most commonly used painkillers in the world. The active ingredient is contained in numerous medicines such as Paracetamol-Mepha, Dafalgan, Panadol, Neocitran, Algifor and others.

The toxicity of the active ingredient can lead to severe liver failure if used incorrectly and can even be fatal in the event of an overdose. The first signs of poisoning may not appear until 24 to 48 hours after ingestion. Signs of poisoning include abdominal pain, nausea, coordination problems and yellow skin.

The challenge of swallowing high doses of painkillers seems to be a recurring trend on social media. Several European countries had already issued corresponding warnings in the summer of 2023.

Translated from German by DeepL/mga

MENAFN01022025000210011054ID1109155566


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search